サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1643930

子宮マニピュレーターの世界市場（2025年～2033年）

Global Uterine Manipulation Devices Market - 2025-2033

出版日
ページ情報
英文 158 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.35円
子宮マニピュレーターの世界市場（2025年～2033年）
出版日: 2025年01月27日
発行: DataM Intelligence
ページ情報: 英文 158 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の子宮マニピュレーターの市場規模は、2024年に2億9,370万米ドルに達し、2033年には4億8,770万米ドルに達すると予測され、予測期間2025年～2033年にはCAGR5.8%で成長する見通しです。

子宮マニピュレーターは、さまざまな低侵襲手術や開腹手術の際に、婦人科外科医が子宮の位置調整、固定、および可動性の確保を支援するために設計された特殊な手術器具です。これらの器具は、腹腔鏡手術、子宮鏡手術、その他の婦人科手術において特に重要であり、正確な子宮の動きを可能にすることで、手術へのアクセス、可視化、そして全体的な手術効率を向上させます。子宮マニピュレーターには、無菌性を高めるシングルユース（使い捨て）モデルと、費用対効果を高めるリユーザブルデザインがあり、臨床の好みに応じて使い分けられます。

子宮マニピュレーターの需要は、低侵襲性婦人科手術の採用の増加、女性の健康問題に対する意識の高まり、手術技術の進歩によって牽引されています。例えば、ScienceDirectに掲載された論文によると、子宮マニピュレーターは低侵襲子宮摘出術で頻繁に使用され、術野へのアクセスを改善し、大腸切除の目印となります。先行研究では、子宮内膜がんの低侵襲手術における子宮マニピュレーターの使用率は42～90%です。

市場力学：

促進要因と抑制要因

婦人科疾患の有病率の上昇

子宮筋腫、子宮内膜症、子宮がんなどの婦人科系疾患の有病率の上昇は、子宮マニピュレーター市場の成長を大きく後押ししており、予測期間中も市場を牽引するとみられています。これらの疾患は外科的介入を必要とすることが多いため、子宮マニピュレーターのような効果的なツールに対する需要が高まっています。

米国国立衛生研究所（NIH）によると、子宮筋腫は、そのほとんどが生殖期を通じて女性を苦しめ、生涯を通じて白人女性の最大70％、アフリカ系アメリカ人女性の80％以上で発見されています。子宮筋腫のある女性の多くは、筋腫核出術（筋腫摘出術）または子宮摘出術を受けますが、いずれも最適な手術結果を得るためには、特に腹腔鏡手術のような低侵襲手術では、子宮マニピュレーターが必要です。

例えば、米国国立衛生研究所（NIH）によると、子宮摘出術は米国で女性に行われる最も一般的な手術の一つであり、毎年約60万件の手術が行われ、そのうちの約10％が子宮頸部温存手術（subtotal）で、これらの手術のかなりの数が子宮筋腫によるものであり、子宮マニピュレーターの需要を生み出しています。

世界保健機関（WHO）によると、子宮内膜症は世界の生殖年齢にある女性および女児のおよそ10％（1億9,000万人）が罹患しており、かなりの割合が症状管理や妊孕性温存のために外科的介入を必要としています。子宮内膜症の手術には、腹腔鏡が用いられることが多く、その際、子宮マニピュレーターを用いて子宮の位置を変えて安定させ、子宮内膜組織の除去を容易にします。

また、米国がん協会は、2024年に米国で新たに子宮体がんと診断される症例は約6万7,880例になると予測しています。治療には子宮摘出術やリンパ節郭清術が行われることが多く、子宮マニピュレーターはより安全で効果的な子宮摘出術のための子宮の位置決めを支援します。

器具関連の合併症のリスク

子宮マニピュレーター市場の成長を妨げる要因として、器具に関連した合併症のリスクが予想されます。子宮穿孔、感染症、不適切な器具の取り扱いなどの合併症は、外科処置の正確さや効率性という点ではこれらの器具の利点であるにもかかわらず、有害な結果につながる可能性があり、医療従事者がこれらの器具を採用することを躊躇させる可能性があります。

子宮穿孔は、マニピュレーターの先端が不注意で子宮壁に穴を開けることで発生し、出血、感染、周辺臓器の損傷といった重大な合併症を引き起こします。例えば、米国国立衛生研究所（NIH）が行った研究によると、低侵襲子宮内膜がん手術における子宮マニピュレーターの使用と子宮穿孔の研究では、子宮穿孔率は11％でした。

子宮マニピュレーターを使用する場合、特に器具が適切に滅菌されていなかったり、手術中に子宮腔が汚染されたりした場合には、感染も懸念されます。例えば、American Journal of Obstetrics & Gynecology誌の研究によると、手術部位感染は腹腔鏡手術の約2～5%で起こっています。しかし、手術器具の滅菌が不適切な場合、この割合は増加する可能性があります。

目次

第1章 市場イントロダクションと範囲

  • レポートの目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • スニペット：タイプ別
  • スニペット：用途別
  • スニペット：エンドユーザー別
  • スニペット：地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 婦人科疾患の罹患率の上昇
    • 抑制要因
      • 器具関連の合併症のリスク
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の研究
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 子宮マニピュレーター市場：タイプ別

  • 使い捨て子宮マニピュレーター
  • リユーザブル子宮マニピュレーター

第6章 子宮マニピュレーター市場：用途別

  • 腹腔鏡下子宮全摘出術（TLH）
  • 腹腔鏡下子宮頸部切除術（LSH）
  • 腹腔鏡下経腟子宮全摘術（LAVH）
  • 仙骨膣固定術
  • その他

第7章 子宮マニピュレーター市場：エンドユーザー別

  • 病院
  • 専門婦人科クリニック
  • 外来手術センター
  • その他

第8章 子宮マニピュレーター市場：地域別の市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第9章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第10章 企業プロファイル

  • B. Braun Melsungen AG
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • CONMED Corporation
  • CooperSurgical Inc.
  • Normedi, a Hologic Company
  • KARL STORZ SE & Co. KG
  • Conkin Surgical Instrument Ltd.
  • Richard Wolf GmbH
  • Purple Surgical
  • Utah Medical Products, Inc.
  • LABORIE MEDICAL TECHNOLOGIES CORP.

第11章 前提条件と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証とバリデーション

第12章 付録

目次
Product Code: MD6748

The global uterine manipulation devices market reached US$ 293.7 million in 2024 and is expected to reach US$ 487.7 million by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033.

Uterine manipulation devices are specialized surgical instruments designed to assist gynecological surgeons in positioning, stabilizing, and mobilizing the uterus during various minimally invasive and open surgical procedures. These devices are particularly critical in laparoscopic, hysteroscopic and other gynecological surgeries, enabling precise uterine movement to enhance surgical access, visualization, and overall procedural efficiency. Uterine manipulators are available in single-use (disposable) models for enhanced sterility and reusable designs for cost-effectiveness, depending on clinical preferences.

The demand for uterine manipulation devices is driven by the increasing adoption of minimally invasive gynecological surgeries, a growing awareness of women's health issues and advancements in surgical technologies. For instance, according to the article publised by the ScienceDirect, a uterine manipulator is frequently utilized during a minimally invasive hysterectomy to improve access to the surgical field and serve as a landmark for colpotomy. Prior studies have indicated rates of uterine manipulator use between 42-90 % during minimally invasive surgeries for endometrial cancer.

Market Dynamics: Drivers & Restraints

Rising prevalence of gynecological disorders

The rising prevalence of gynecological disorders such as uterine fibroids, endometriosis and uterine cancer is significantly driving the growth of the uterine manipulation devices market and is expected to drive the market over the forecast period. As these conditions often require surgical intervention, the demand for effective tools, such as uterine manipulators, has risen.

According to the National Institute of Health (NIH), Uterine leiomyomas also known as fibroids, mostly afflict women throughout their reproductive years and are detected in up to 70% of white women and more than 80% of African-American women over their lifespan. Many women with fibroids undergo myomectomy (fibroid removal) or hysterectomy, both of which require uterine manipulation devices for optimal surgical outcomes, especially in minimally invasive procedures like laparoscopic surgeries.

For instance, according to the National Institute of Health (NIH), hysterectomy is one of the most common surgeries performed in women in the United States, totaling roughly 600,000 procedures each year, with approximately 10% of procedures being subtotal (cervix-preserving) and a significant number of these surgeries are due to fibroids, creating demand for uterine manipulators.

According to the World Health Organization (WHO), endometriosis affects roughly 10% (190 million) of reproductive-age women and girls globally, with a significant percentage requiring surgical intervention for symptom management or fertility preservation. Surgery for endometriosis often involves laparoscopy, during which uterine manipulation devices are used to reposition and stabilize the uterus, facilitating the removal of endometrial tissue.

Additionally, the American Cancer Society forecasts for cancer of the uterus in the United States in 2024 approximately 67,880 new cases of uterine cancer will be diagnosed. Treatment often involves hysterectomy or lymphadenectomy, where uterine manipulation devices assist in positioning the uterus for safer and more effective surgical removal.

Risk of device-related complications

The risk of device-related complications is expected to hamper the growth of the uterine manipulation devices market. Despite the advantages these devices offer in terms of precision and efficiency during surgical procedures, complications such as uterine perforation, infection, and improper device handling can lead to adverse outcomes, which may deter healthcare providers from adopting these devices.

Uterine perforation occurs when the manipulator tip inadvertently punctures the uterine wall, leading to significant complications such as bleeding, infection, and injury to surrounding organs. For instance, according to the study conducted by the National Institute of Health (NIH), the use of uterine manipulators and uterine perforation in minimally invasive endometrial cancer surgery study found a uterine perforation rate of 11%.

Infection is another concern when using uterine manipulation devices, particularly when the device is not properly sterilized or if the uterine cavity is contaminated during the procedure. For instance, according to a study in the American Journal of Obstetrics & Gynecology, surgical site infections occur in about 2-5% of laparoscopic surgeries. However, this rate can increase in the case of improper sterilization of surgical tools.

Segment Analysis

The global uterine manipulation devices market is segmented based on type, application, end-user and region.

Application:

The total laparoscopic hysterectomy (TLH) segment is expected to dominate the uterine manipulation devices market share

Total laparoscopic hysterectomy (TLH) is a minimally invasive surgical procedure used to remove the uterus, and it is the dominant segment in the uterine manipulation devices market. The increasing preference for TLH, due to its numerous advantages over traditional open surgery, such as reduced recovery time, lower risk of complications, and better cosmetic outcomes, has made it a key driver of demand for uterine manipulation devices.

The demand for uterine manipulation devices in TLH is particularly high because these devices enhance the precision of the surgery by stabilizing and positioning the uterus, which is vital for laparoscopic access. For instance, according to the American College of Obstetricians and Gynecologists, 70-80% of hysterectomies in the U.S. are now performed laparoscopically, with TLH being the preferred method, further driving the growth of uterine manipulation devices in this segment.

The adoption rate of TLH is growing due to its many advantages over abdominal hysterectomy, such as faster recovery time, less blood loss, and fewer post-operative complications. As more hospitals and clinics adopt TLH as the standard for hysterectomy, the use of uterine manipulation devices has correspondingly increased. For instance, in the U.S., TLH procedures increased by over 15% annually from 2010 to 2020, and this growth is expected to continue as TLH becomes the preferred method for hysterectomy worldwide.

Geographical Analysis

North America is expected to hold a significant position in the uterine manipulation devices market share

North America especially the United States performs hundreds of thousands of hysterectomies annually, the majority of which are now laparoscopic procedures. With TLH being the most common method, uterine manipulation devices are in high demand to ensure the success and precision of these surgeries. For instance, according to the National Institute of Health (NIH), hysterectomy is one of the most common surgeries performed in women in the United States, with 600,000 procedures each year.

North American medical device manufacturers are leaders in developing and improving uterine manipulation devices, incorporating advanced features such as better ergonomics, user-friendly interfaces, and enhanced safety features. This innovation attracts hospitals and surgical centers in the region to adopt these devices more frequently.

For instance, leading manufacturers in North America, like CooperSurgical, produce high-quality uterine manipulators that are widely used in TLH procedures across the region. The RUMI II manipulator is a notable example, widely adopted in U.S. hospitals for its advanced design and effectiveness in TLH.

Asia-Pacific is growing at the fastest pace in the uterine manipulation devices market

In Asia-Pacific, especially in Japan, China and India, laparoscopic surgery, including total laparoscopic hysterectomy, is becoming the preferred method for hysterectomy in the region due to its minimally invasive nature, which reduces recovery times and healthcare costs. As more surgeons and hospitals in the region adopt minimally invasive techniques, the demand for uterine manipulators, which are essential in laparoscopic procedures, has surged.

For instance, according to the National Institute of Health, in Japan, over 50% of hysterectomies are now performed laparoscopically, and this trend is rapidly growing across other APAC nations. In China, laparoscopic hysterectomy adoption rates have increased by 18-20% annually over the past decade.

The Asia-Pacific region is becoming a global hub for medical tourism, with countries like Thailand, India, and Malaysia attracting patients for affordable, high-quality medical procedures. Many of these patients undergo laparoscopic surgeries, which require uterine manipulation devices. The increase in surgical volume, driven by medical tourism and local patients, boosts the demand for uterine manipulators, particularly in countries with established medical tourism industries.

Competitive Landscape

The major global players in the uterine manipulation devices market include B. Braun Melsungen AG, CONMED Corporation, CooperSurgical Inc., Normedi, a Hologic Company, KARL STORZ SE & Co. KG, Conkin Surgical Instrument Ltd., Richard Wolf GmbH, Purple Surgical, Utah Medical Products, Inc., LABORIE MEDICAL TECHNOLOGIES CORP. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global uterine manipulation devices market report delivers a detailed analysis with 62 key tables, more than 54 visually impactful figures, and 158 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Gynecological Disorders
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Device-Related Complications
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics

5. Uterine Manipulation Devices Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Disposable Uterine Manipulators*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Reusable Uterine Manipulators

6. Uterine Manipulation Devices Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Total Laparoscopy Hysterectomy (TLH) *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Laparoscopic Supracervical Hysterectomy (LSH)
  • 6.4. Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
  • 6.5. Sacrocolpopexy
  • 6.6. Others

7. Uterine Manipulation Devices Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Specialized Gynecology Clinics
  • 7.4. Ambulatory Surgical Centers
  • 7.5. Others

8. Uterine Manipulation Devices Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. B. Braun Melsungen AG*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Financial Overview
    • 10.1.4. Key Developments
    • 10.1.5. SWOT Analysis
  • 10.2. CONMED Corporation
  • 10.3. CooperSurgical Inc.
  • 10.4. Normedi, a Hologic Company
  • 10.5. KARL STORZ SE & Co. KG
  • 10.6. Conkin Surgical Instrument Ltd.
  • 10.7. Richard Wolf GmbH
  • 10.8. Purple Surgical
  • 10.9. Utah Medical Products, Inc.
  • 10.10. LABORIE MEDICAL TECHNOLOGIES CORP.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us